The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer

The post-transcriptional control of gene expression mediated by RNA-binding proteins (RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is essential to determine tumor cell fate and thus is a major determinant in cancerogenesis. The IGF2 mRNA binding protein family (IGF2BPs) comprises three RB...

Full description

Saved in:
Bibliographic Details
Published inSeminars in cancer biology Vol. 29; pp. 3 - 12
Main Authors Lederer, Marcell, Bley, Nadine, Schleifer, Christian, Hüttelmaier, Stefan
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2014
Subjects
Antigens, Neoplasm - genetics
Cell Proliferation
Cell Transformation, Neoplastic - genetics
CRD-BP
Drug Resistance, Neoplasm - genetics
Gene Expression Regulation, Neoplastic
Hematology, Oncology and Palliative Medicine
Humans
IGF2 mRNA-binding protein
IGF2BP
IMP
Neoplasm Metastasis - genetics
Neoplasm Metastasis - pathology
Neoplasms - genetics
Neoplasms - pathology
RNA-Binding Proteins - biosynthesis
RNA-Binding Proteins - genetics
VICKZ
VICKZ
CRD-BP
IGF2BP
IGF2 mRNA-binding protein
IMP
Online AccessGet full text

Cover

Abstract The post-transcriptional control of gene expression mediated by RNA-binding proteins (RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is essential to determine tumor cell fate and thus is a major determinant in cancerogenesis. The IGF2 mRNA binding protein family (IGF2BPs) comprises three RBPs. Two members of the family, IGF2BP1 and IGF2BP3, are bona fide oncofetal proteins, which are de novo synthesized in various human cancers. In vitro studies revealed that IGF2BPs serve as post-transcriptional fine-tuners modulating the expression of genes implicated in the control of tumor cell proliferation, survival, chemo-resistance and metastasis. Consistently, the expression of both IGF2BP family members was reported to correlate with an overall poor prognosis and metastasis in various human cancers. Due to the fact that most reports used a pan-IGF2BP antibody for studying IGF2BP expression in cancer, paralogue-specific functions can barely be evaluated at present. Nonetheless, the accordance of IGF2BPs’ role in promoting an aggressive phenotype of tumor-derived cells in vitro and their upregulated expression in aggressive malignancies provides strong evidence that IGF2BPs are powerful post-transcriptional oncogenes enhancing tumor growth, drug-resistance and metastasis. This suggests IGF2BPs as powerful biomarkers and candidate targets for cancer therapy.
AbstractList The post-transcriptional control of gene expression mediated by RNA-binding proteins (RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is essential to determine tumor cell fate and thus is a major determinant in cancerogenesis. The IGF2 mRNA binding protein family (IGF2BPs) comprises three RBPs. Two members of the family, IGF2BP1 and IGF2BP3, are bona fide oncofetal proteins, which are de novo synthesized in various human cancers. In vitro studies revealed that IGF2BPs serve as post-transcriptional fine-tuners modulating the expression of genes implicated in the control of tumor cell proliferation, survival, chemo-resistance and metastasis. Consistently, the expression of both IGF2BP family members was reported to correlate with an overall poor prognosis and metastasis in various human cancers. Due to the fact that most reports used a pan-IGF2BP antibody for studying IGF2BP expression in cancer, paralogue-specific functions can barely be evaluated at present. Nonetheless, the accordance of IGF2BPs' role in promoting an aggressive phenotype of tumor-derived cells in vitro and their upregulated expression in aggressive malignancies provides strong evidence that IGF2BPs are powerful post-transcriptional oncogenes enhancing tumor growth, drug-resistance and metastasis. This suggests IGF2BPs as powerful biomarkers and candidate targets for cancer therapy.
The post-transcriptional control of gene expression mediated by RNA-binding proteins (RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is essential to determine tumor cell fate and thus is a major determinant in cancerogenesis. The IGF2 mRNA binding protein family (IGF2BPs) comprises three RBPs. Two members of the family, IGF2BP1 and IGF2BP3, are bona fide oncofetal proteins, which are de novo synthesized in various human cancers. In vitro studies revealed that IGF2BPs serve as post-transcriptional fine-tuners modulating the expression of genes implicated in the control of tumor cell proliferation, survival, chemo-resistance and metastasis. Consistently, the expression of both IGF2BP family members was reported to correlate with an overall poor prognosis and metastasis in various human cancers. Due to the fact that most reports used a pan-IGF2BP antibody for studying IGF2BP expression in cancer, paralogue-specific functions can barely be evaluated at present. Nonetheless, the accordance of IGF2BPs' role in promoting an aggressive phenotype of tumor-derived cells in vitro and their upregulated expression in aggressive malignancies provides strong evidence that IGF2BPs are powerful post-transcriptional oncogenes enhancing tumor growth, drug-resistance and metastasis. This suggests IGF2BPs as powerful biomarkers and candidate targets for cancer therapy.The post-transcriptional control of gene expression mediated by RNA-binding proteins (RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is essential to determine tumor cell fate and thus is a major determinant in cancerogenesis. The IGF2 mRNA binding protein family (IGF2BPs) comprises three RBPs. Two members of the family, IGF2BP1 and IGF2BP3, are bona fide oncofetal proteins, which are de novo synthesized in various human cancers. In vitro studies revealed that IGF2BPs serve as post-transcriptional fine-tuners modulating the expression of genes implicated in the control of tumor cell proliferation, survival, chemo-resistance and metastasis. Consistently, the expression of both IGF2BP family members was reported to correlate with an overall poor prognosis and metastasis in various human cancers. Due to the fact that most reports used a pan-IGF2BP antibody for studying IGF2BP expression in cancer, paralogue-specific functions can barely be evaluated at present. Nonetheless, the accordance of IGF2BPs' role in promoting an aggressive phenotype of tumor-derived cells in vitro and their upregulated expression in aggressive malignancies provides strong evidence that IGF2BPs are powerful post-transcriptional oncogenes enhancing tumor growth, drug-resistance and metastasis. This suggests IGF2BPs as powerful biomarkers and candidate targets for cancer therapy.
Abstract The post-transcriptional control of gene expression mediated by RNA-binding proteins (RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is essential to determine tumor cell fate and thus is a major determinant in cancerogenesis. The IGF2 mRNA binding protein family (IGF2BPs) comprises three RBPs. Two members of the family, IGF2BP1 and IGF2BP3, are bona fide oncofetal proteins, which are de novo synthesized in various human cancers. In vitro studies revealed that IGF2BPs serve as post-transcriptional fine-tuners modulating the expression of genes implicated in the control of tumor cell proliferation, survival, chemo-resistance and metastasis. Consistently, the expression of both IGF2BP family members was reported to correlate with an overall poor prognosis and metastasis in various human cancers. Due to the fact that most reports used a pan-IGF2BP antibody for studying IGF2BP expression in cancer, paralogue-specific functions can barely be evaluated at present. Nonetheless, the accordance of IGF2BPs’ role in promoting an aggressive phenotype of tumor-derived cells in vitro and their upregulated expression in aggressive malignancies provides strong evidence that IGF2BPs are powerful post-transcriptional oncogenes enhancing tumor growth, drug-resistance and metastasis. This suggests IGF2BPs as powerful biomarkers and candidate targets for cancer therapy.
Author Hüttelmaier, Stefan
Bley, Nadine
Schleifer, Christian
Lederer, Marcell
Author_xml – sequence: 1
  givenname: Marcell
  surname: Lederer
  fullname: Lederer, Marcell
  organization: Division of Molecular Cell Biology, Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Heinrich-Damerow-Strasse 1, 06120 Halle, Germany
– sequence: 2
  givenname: Nadine
  surname: Bley
  fullname: Bley, Nadine
  organization: Division of Molecular Cell Biology, Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Heinrich-Damerow-Strasse 1, 06120 Halle, Germany
– sequence: 3
  givenname: Christian
  surname: Schleifer
  fullname: Schleifer, Christian
  organization: Division of Molecular Cell Biology, Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Heinrich-Damerow-Strasse 1, 06120 Halle, Germany
– sequence: 4
  givenname: Stefan
  surname: Hüttelmaier
  fullname: Hüttelmaier, Stefan
  email: stefan.huettelmaier@medizin.uni-halle.de
  organization: Division of Molecular Cell Biology, Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Heinrich-Damerow-Strasse 1, 06120 Halle, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25068994$$D View this record in MEDLINE/PubMed
BookMark eNqNUk1v1DAQtVAr-gF_AXwsh4SxndjJAdBS0bJSBQiKxM1KnAl4Sexie5H673HYtodKiJ489rz3ZuZ5jsie8w4Jec6gZMDky00ZcTadMxhKDqwqQZUA8hE5ZNDKQsga9pa4qopatd8OyFGMGwBoK1Y9Jge8Btm0bXVI1pc_kAY_IfUjTTn2zvgRUzfR9fkZp_PnD6uit26w7ju9Cj6hdVTQkyX59pN4QfN118cTsj92U8SnN-cx-Xr27vL0fXHx8Xx9uroojGRNKhqjZC25QM6ZEErVvawrYEPLm0GMA8gacWR9K3oFMs_BRyFVfhgr00gpQRyTk51u7ubXFmPSs40Gp6lz6LdRs8wRDWdNnaHPbqDbfsZBXwU7d-Fa346fAa92ABN8jAFHbWzqkvUuhc5OmoFe7NYbfWe3XuzWoHS2O_PVPf5tif8zVzsmZqt-25yNxmKGDTagSXrw9gEar-9pmMk6a7rpJ15j3PhtcPknNNORa9BflnVYtoFVfzdBZYE3_xZ4UAt_AFq7xNc
CitedBy_id crossref_primary_10_1016_j_exphem_2020_07_004
crossref_primary_10_1172_JCI80046
crossref_primary_10_1038_s41388_024_03099_w
crossref_primary_10_1038_s41419_023_06049_8
crossref_primary_10_1186_s12916_021_02148_5
crossref_primary_10_1016_j_omtn_2022_10_002
crossref_primary_10_1016_j_omtn_2021_08_029
crossref_primary_10_1016_j_biopha_2024_116566
crossref_primary_10_3390_ijms23179552
crossref_primary_10_1007_s11060_015_1916_9
crossref_primary_10_3390_cancers13071505
crossref_primary_10_1038_s41419_024_06564_2
crossref_primary_10_1016_j_aaf_2017_10_008
crossref_primary_10_1186_s40164_023_00429_8
crossref_primary_10_1002_dc_25113
crossref_primary_10_1016_j_jbc_2022_101649
crossref_primary_10_1186_s10020_022_00557_7
crossref_primary_10_1038_s41588_019_0424_9
crossref_primary_10_1016_j_lfs_2020_118413
crossref_primary_10_1155_2022_5774339
crossref_primary_10_3390_ijms20164067
crossref_primary_10_1101_gad_287540_116
crossref_primary_10_1111_ajco_13941
crossref_primary_10_1039_D3MO00171G
crossref_primary_10_1093_nar_gkaa653
crossref_primary_10_1016_j_bbadis_2024_167183
crossref_primary_10_1016_j_ccell_2019_12_007
crossref_primary_10_1002_ijc_32124
crossref_primary_10_1093_nar_gky1012
crossref_primary_10_1007_s12020_017_1249_x
crossref_primary_10_1002_cam4_2675
crossref_primary_10_3389_fmolb_2019_00065
crossref_primary_10_18632_oncotarget_8961
crossref_primary_10_1186_s13059_020_02076_2
crossref_primary_10_1073_pnas_1614265114
crossref_primary_10_3389_fimmu_2020_01292
crossref_primary_10_1172_jci_insight_162060
crossref_primary_10_1093_braincomms_fcaa159
crossref_primary_10_1101_cshperspect_a034967
crossref_primary_10_1038_s41598_017_18112_4
crossref_primary_10_3389_fgene_2021_743738
crossref_primary_10_3389_fonc_2021_711207
crossref_primary_10_3390_cancers14092121
crossref_primary_10_1007_s12672_024_01432_z
crossref_primary_10_1038_s41419_021_04245_y
crossref_primary_10_3892_mmr_2017_7943
crossref_primary_10_1002_mc_23502
crossref_primary_10_1158_0008_5472_CAN_23_0604
crossref_primary_10_3389_fonc_2020_00994
crossref_primary_10_3389_fgene_2022_1021163
crossref_primary_10_1016_j_str_2025_01_022
crossref_primary_10_2174_1568009622666220301145013
crossref_primary_10_1016_j_jprot_2018_07_013
crossref_primary_10_1002_dc_24958
crossref_primary_10_1016_j_semcancer_2022_03_018
crossref_primary_10_1016_j_heliyon_2024_e24414
crossref_primary_10_1007_s13577_022_00725_1
crossref_primary_10_1016_j_tranon_2022_101434
crossref_primary_10_1093_nar_gky229
crossref_primary_10_1186_s13046_022_02466_3
crossref_primary_10_3390_ijms21186835
crossref_primary_10_1007_s11033_024_09230_0
crossref_primary_10_1002_prca_201600167
crossref_primary_10_18632_aging_203347
crossref_primary_10_3892_ijmm_2019_4441
crossref_primary_10_1007_s11010_024_05040_x
crossref_primary_10_1007_s12185_023_03605_y
crossref_primary_10_1016_j_cbi_2023_110408
crossref_primary_10_1039_D0MO00113A
crossref_primary_10_3389_fneur_2022_963508
crossref_primary_10_1038_s41467_023_42571_1
crossref_primary_10_1186_s12935_022_02455_8
crossref_primary_10_1016_j_sjbs_2023_103569
crossref_primary_10_1016_j_oraloncology_2016_03_001
crossref_primary_10_1186_s12943_023_01771_5
crossref_primary_10_1038_s41420_023_01727_0
crossref_primary_10_1080_15476286_2019_1673657
crossref_primary_10_3389_fendo_2018_00178
crossref_primary_10_1080_15384047_2017_1323601
crossref_primary_10_1186_s40246_024_00632_6
crossref_primary_10_1155_2022_7240646
crossref_primary_10_1038_s41467_022_34558_1
crossref_primary_10_3390_cancers15184489
crossref_primary_10_7554_eLife_27155
crossref_primary_10_1186_s12967_023_04235_y
crossref_primary_10_3389_fonc_2017_00158
crossref_primary_10_3389_fonc_2019_01570
crossref_primary_10_1158_1535_7163_MCT_20_0649
crossref_primary_10_1186_s10020_025_01078_9
crossref_primary_10_1177_1533033820917332
crossref_primary_10_1016_j_bbamcr_2023_119542
crossref_primary_10_1038_s41467_019_12193_7
crossref_primary_10_1158_1078_0432_CCR_17_2602
crossref_primary_10_1016_j_bcp_2024_116555
crossref_primary_10_3389_fgene_2017_00048
crossref_primary_10_1016_j_ejmech_2024_116241
crossref_primary_10_1038_s41419_021_03489_y
crossref_primary_10_1038_s43018_021_00315_4
crossref_primary_10_1016_j_ccell_2020_02_004
crossref_primary_10_1097_HEP_0000000000000918
crossref_primary_10_1038_s41467_024_53400_4
crossref_primary_10_1002_1873_3468_12621
crossref_primary_10_1002_hep_31850
crossref_primary_10_1007_s00417_019_04410_2
crossref_primary_10_18632_oncotarget_14287
crossref_primary_10_3389_fonc_2024_1347402
crossref_primary_10_3389_fonc_2022_801226
crossref_primary_10_1038_s42003_022_03878_9
crossref_primary_10_3390_biology10050407
crossref_primary_10_1097_MD_0000000000027304
crossref_primary_10_1038_s41698_022_00283_7
crossref_primary_10_1016_j_bbrc_2019_03_206
crossref_primary_10_1016_j_isci_2023_107447
crossref_primary_10_1016_j_humpath_2016_12_028
crossref_primary_10_18632_oncotarget_21280
crossref_primary_10_1016_j_bbrc_2022_08_040
crossref_primary_10_1186_s12885_021_08550_9
crossref_primary_10_1158_0008_5472_CAN_21_1222
crossref_primary_10_1038_s41467_023_44576_2
crossref_primary_10_1111_jcmm_16003
crossref_primary_10_18632_aging_101785
crossref_primary_10_1038_s41419_024_07257_6
crossref_primary_10_1038_s41467_024_51634_w
crossref_primary_10_1186_s13000_020_00951_x
crossref_primary_10_2174_1389557523666230509122402
crossref_primary_10_1186_s40364_023_00499_0
crossref_primary_10_1093_neuonc_noaa157
crossref_primary_10_3390_cancers16203502
crossref_primary_10_1038_s41598_024_60438_3
crossref_primary_10_1074_jbc_M117_782052
crossref_primary_10_7554_eLife_31347
crossref_primary_10_1016_j_semcancer_2022_03_025
crossref_primary_10_1128_MCB_00352_17
crossref_primary_10_1007_s12672_025_01880_1
crossref_primary_10_1111_jcmm_15848
crossref_primary_10_3389_fphar_2021_775084
crossref_primary_10_1080_09712119_2022_2116441
crossref_primary_10_1177_1535370220936145
crossref_primary_10_7554_eLife_13463
crossref_primary_10_1007_s00109_024_02488_8
crossref_primary_10_1016_j_bbrc_2018_04_019
crossref_primary_10_1111_cns_14296
crossref_primary_10_3889_oamjms_2021_6948
crossref_primary_10_3389_fcell_2019_00363
crossref_primary_10_1371_journal_pone_0259197
crossref_primary_10_3389_fimmu_2023_1071675
crossref_primary_10_1016_j_str_2021_05_001
crossref_primary_10_1038_s41467_020_16306_5
crossref_primary_10_1097_PAI_0000000000000416
crossref_primary_10_1016_j_bbrc_2018_05_057
crossref_primary_10_3389_fonc_2021_633024
crossref_primary_10_3390_toxins15060360
crossref_primary_10_1080_15548627_2021_1917131
crossref_primary_10_1002_jcp_28483
crossref_primary_10_1089_dna_2020_6136
crossref_primary_10_1016_j_ccell_2016_02_008
crossref_primary_10_3390_ijms21114190
crossref_primary_10_1158_0008_5472_CAN_19_4032
crossref_primary_10_1002_cac2_12161
crossref_primary_10_61622_rbgo_2024rbgo61
crossref_primary_10_1158_0008_5472_CAN_19_3626
crossref_primary_10_3390_ijms21072549
crossref_primary_10_1093_abbs_gmz048
crossref_primary_10_3389_fcell_2024_1308102
crossref_primary_10_1016_j_bbrc_2018_05_040
crossref_primary_10_1002_ctm2_1361
crossref_primary_10_1016_j_bbrc_2020_05_002
crossref_primary_10_1016_j_jare_2025_01_008
crossref_primary_10_1186_s10020_024_00936_2
crossref_primary_10_1371_journal_pone_0152918
crossref_primary_10_1002_1873_3468_13228
crossref_primary_10_1016_j_canlet_2017_11_039
crossref_primary_10_1089_thy_2020_0589
crossref_primary_10_1096_fj_202200751RR
crossref_primary_10_1016_j_celrep_2024_114756
crossref_primary_10_1016_j_cyto_2024_156750
crossref_primary_10_3389_fonc_2021_795467
crossref_primary_10_1016_j_juro_2015_11_067
crossref_primary_10_1200_JCO_2014_55_9880
crossref_primary_10_1111_cas_12700
crossref_primary_10_1016_j_prostaglandins_2024_106832
crossref_primary_10_3892_ol_2017_5735
crossref_primary_10_1038_s12276_022_00795_z
crossref_primary_10_1093_nar_gkw099
crossref_primary_10_1177_0963689720964382
crossref_primary_10_3389_fonc_2022_970833
crossref_primary_10_1186_s13045_018_0628_y
crossref_primary_10_1016_j_yexcr_2022_113024
crossref_primary_10_1038_s41467_018_04006_0
crossref_primary_10_1186_s12957_024_03415_4
crossref_primary_10_1038_s42003_024_07383_z
Cites_doi 10.1002/hed.21856
10.1111/j.1464-410X.2011.10703.x
10.1101/gad.2042311
10.1074/jbc.C112.442319
10.1111/j.1600-0714.2011.01019.x
10.1084/jem.189.7.1101
10.1007/s00432-011-1129-3
10.1186/1471-2407-10-59
10.1111/j.1600-0714.2012.01178.x
10.1016/j.prp.2014.01.018
10.1038/nn1773
10.1038/modpathol.3801016
10.1016/j.humpath.2009.05.003
10.1002/hed.21457
10.1038/modpathol.2012.84
10.1016/j.humpath.2006.11.011
10.1016/j.humpath.2009.10.004
10.1016/j.humpath.2010.01.014
10.5858/arpa.2012-0305-OA
10.1097/PAI.0b013e3182143399
10.1158/1078-0432.CCR-07-2039
10.1016/j.humpath.2014.03.005
10.1097/PAS.0b013e3181483ff8
10.1097/NEN.0b013e31829023dd
10.1093/nar/gkq1032
10.1002/hep.26997
10.1016/j.humpath.2011.05.012
10.1002/dc.20739
10.1172/JCI65859
10.1038/sj.onc.1210563
10.1002/dc.21571
10.1097/PGP.0b013e31826ddc4e
10.1101/gad.1862910
10.1074/jbc.M111.263913
10.1016/j.humpath.2007.12.012
10.1159/000357199
10.1016/j.eururo.2013.12.008
10.1002/cncr.23296
10.1101/gad.6.4.642
10.1016/j.humpath.2013.04.002
10.1111/j.1349-7006.2011.02100.x
10.1093/nar/gkt410
10.1002/ijc.28808
10.1074/jbc.M500270200
10.1016/j.ijsu.2012.11.021
10.1111/j.1365-2559.2011.04091.x
10.3324/haematol.10724
10.1038/nn1775
10.1261/rna.1175909
10.1016/j.ygyno.2013.04.020
10.1016/j.oraloncology.2011.07.017
10.1128/MCB.22.13.4535-4543.2002
10.1101/gad.177428.111
10.1016/j.ejca.2012.06.021
10.1016/j.bcmd.2011.02.005
10.1097/PAS.0b013e3182189223
10.1016/j.humpath.2011.12.020
10.1016/j.humpath.2013.04.011
10.1007/s00401-006-0063-y
10.1016/S0016-5085(03)00402-5
10.1016/S1470-2045(06)70732-X
10.1016/j.humpath.2009.05.005
10.1261/rna.1195709
10.1186/1746-1596-7-165
10.3892/ol.2013.1458
10.1158/0008-5472.CAN-03-2927
10.1038/onc.2011.620
10.1016/j.humpath.2012.12.003
10.1371/journal.pone.0010770
10.1038/modpathol.2013.97
10.1016/j.celrep.2014.03.015
10.1016/j.molcel.2009.06.007
10.1016/j.fertnstert.2013.02.002
10.1111/his.12409
10.1128/MCB.17.4.2158
10.1016/j.humpath.2010.05.004
10.1016/j.humpath.2012.12.020
10.1245/s10434-009-0648-5
10.2353/ajpath.2007.060790
10.1074/jbc.M110.178012
10.1093/carcin/bgs258
10.1016/j.cell.2010.03.009
10.1007/s00018-012-1186-z
10.1101/gad.209130.112
10.1111/j.1600-0560.2009.01428.x
10.1038/nature12785
10.1371/journal.pone.0050621
10.4081/ejh.2013.e6
10.1101/gad.177642.111
10.5858/2009-0652-OAR2
10.1038/modpathol.2010.117
10.1074/mcp.M600346-MCP200
10.1038/sj.onc.1201110
10.1111/his.12096
10.1038/modpathol.3800960
10.1002/jso.22108
10.1016/j.humpath.2010.06.003
10.1097/PDM.0b013e3181b6a528
10.1515/hsz-2013-0111
10.1002/hep.22459
10.1245/s10434-009-0446-0
10.1002/cncr.23484
10.3727/096504008786991639
10.1309/AJCPQDQXJ4FNRFQB
10.1158/1078-0432.CCR-08-0504
10.1097/01.pas.0000149688.98333.54
10.1128/MCB.19.2.1262
10.5858/2009-0617-OAR2
10.1038/nature04115
10.1677/JME-09-0016
10.1016/j.humpath.2012.06.010
10.1038/modpathol.2008.206
10.1007/s11060-013-1274-4
10.1016/j.humpath.2009.03.019
10.1038/sj.emboj.7601039
10.1007/s00432-014-1639-x
10.1007/s12022-009-9079-x
10.1038/modpathol.2009.128
10.1111/j.1464-410X.2012.11149.x
10.1186/1471-2407-10-341
10.1016/j.humpath.2008.07.009
10.1016/S0960-9822(03)00044-7
10.4161/cam.20628
10.1002/dc.23029
10.1530/rep.1.00664
10.1093/nar/gkh754
10.1038/onc.2013.252
10.1038/cddis.2013.545
ContentType Journal Article
Copyright 2014 The Authors
The Authors
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.
Copyright_xml – notice: 2014 The Authors
– notice: The Authors
– notice: Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.semcancer.2014.07.006
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1096-3650
EndPage 12
ExternalDocumentID 25068994
10_1016_j_semcancer_2014_07_006
S1044579X14000947
1_s2_0_S1044579X14000947
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
ADUVX
ADVLN
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CAG
COF
CS3
DM4
EBS
EFBJH
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HX~
HZ~
IH2
IHE
J1W
KOM
LG5
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RNS
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UDS
UNMZH
XPP
Z5R
ZMT
ZU3
~G-
0SF
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
NCXOZ
RIG
6I.
AAFTH
AAIAV
ABYKQ
AJBFU
DOVZS
EFLBG
AAYXX
AGRNS
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c618t-8c765623e22133775b65401d928d3fd065eef1b93b7063652f367f1bf4c866603
IEDL.DBID .~1
ISSN 1044-579X
1096-3650
IngestDate Fri Jul 11 03:03:37 EDT 2025
Thu Apr 03 06:52:49 EDT 2025
Tue Jul 01 00:25:34 EDT 2025
Thu Apr 24 23:11:52 EDT 2025
Fri Feb 23 02:17:45 EST 2024
Sun Feb 23 10:18:42 EST 2025
Tue Aug 26 20:01:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords VICKZ
CRD-BP
IGF2BP
IGF2 mRNA-binding protein
IMP
Language English
License http://creativecommons.org/licenses/by-nc-sa/3.0
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c618t-8c765623e22133775b65401d928d3fd065eef1b93b7063652f367f1bf4c866603
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1044579X14000947
PMID 25068994
PQID 1652382185
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1652382185
pubmed_primary_25068994
crossref_citationtrail_10_1016_j_semcancer_2014_07_006
crossref_primary_10_1016_j_semcancer_2014_07_006
elsevier_sciencedirect_doi_10_1016_j_semcancer_2014_07_006
elsevier_clinicalkeyesjournals_1_s2_0_S1044579X14000947
elsevier_clinicalkey_doi_10_1016_j_semcancer_2014_07_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-12-01
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-12-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Seminars in cancer biology
PublicationTitleAlternate Semin Cancer Biol
PublicationYear 2014
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Zirkel, Lederer, Stohr, Pazaitis, Huttelmaier (bib0190) 2013; 41
Ostareck-Lederer, Ostareck, Cans, Neubauer, Bomsztyk, Superti-Furga (bib0115) 2002; 22
Mhawech-Fauceglia, Yan, Liu, Pejovic (bib0290) 2013; 62
Wachter, Schlabrakowski, Hoegel, Kristiansen, Hartmann, Riener (bib0430) 2011; 35
Kunita, Kashima, Morishita, Fukayama, Kato, Tsuruo (bib0235) 2007; 170
Kobel, Weidensdorfer, Reinke, Lederer, Schmitt, Zeng (bib0330) 2007; 26
Goodman, Zhang, Cheng, Jiang (bib0485) 2014
King, Pasha, Roullet, Zhang, Bagg (bib0645) 2009; 40
Shi, Liu, Wang, Prichard, Lin (bib0400) 2013; 44
Hwang, Xianglan, Park, Chung (bib0225) 2012; 33
Mueller-Pillasch, Lacher, Wallrapp, Micha, Zimmerhackl, Hameister (bib0045) 1997; 14
Tessier, Doyle, Clark, Pitot, Ross (bib0240) 2004; 64
Ueki, Shimizu, Masuda, Yamaguchi, Ishikawa, Sugihara (bib0085) 2012; 7
Kim, Cha (bib0555) 2012; 138
Gutschner, Hammerle, Pazaitis, Bley, Fiskin, Uckelmann (bib0175) 2014; 59
Pryor, Bourne, Yang, Spaulding, Scott, Xu (bib0585) 2008; 21
Mentrikoski, Ma, Pryor, McMahon, Yang, Spaulding (bib0590) 2009; 22
Vikesaa, Hansen, Jonson, Borup, Wewer, Christiansen (bib0205) 2006; 25
Suvasini, Shruti, Thota, Shinde, Friedmann-Morvinski, Nawaz (bib0155) 2011; 286
Vranic, Gurjeva, Frkovic-Grazio, Palazzo, Tawfik, Gatalica (bib0270) 2011; 19
Walter, Prasad, Lu, Quinlan, Edmiston, Khan (bib0255) 2009; 40
Kim, Cha (bib0550) 2011; 47
Davidson, Rosenfeld, Holth, Hellesylt, Trope, Reich (bib0335) 2014; 45
Zhou, Chen, Yang, Wang, Lu, Ji (bib0620) 2014; 116
Vercellini, Cribiu, Del Gobbo, Carcangiu, Somigliana, Bosari (bib0295) 2013; 99
Jiang, Chu, Woda, Rock, Liu, Hsieh (bib0465) 2006; 7
Tang, Wei, Ge, Jian, Liu, Zhong (bib0650) 2013; 44
Szarvas, Tschirdewahn, Niedworok, Kramer, Sevcenco, Reis (bib0445) 2014; 135
Lee, Xylinas, Rieken, Khani, Klatte, Wood (bib0510) 2014; 66
Samanta, Sharma, Khan, Mercurio (bib0210) 2012; 31
Morimatsu, Aishima, Yamamoto, Hayashi, Nakata, Oda (bib0440) 2013; 44
Stohr, Huttelmaier (bib0195) 2012; 6
Slosar, Vohra, Prasad, Fischer, Quinlan, Khan (bib0615) 2009; 20
Lastra, Ou, Reilly, Lawrence, Baloch, Brooks (bib0280) 2014; 42
Zhang, Garcia-Buitrago, Koru-Sengul, Schuman, Ganjei-Azar (bib0325) 2013; 32
Chen, Cornejo, Ye, Wu, Liang, Jiang (bib0525) 2013; 44
Szarvas, vom Dorp, Niedworok, Melchior-Becker, Fischer, Singer (bib0490) 2012; 110
Jonson, Vikesaa, Krogh, Nielsen, Hansen, Borup (bib0095) 2007; 6
Asioli, Erickson, Righi, Jin, Volante, Jenkins (bib0605) 2010; 23
Sidoni, Cartaginese (bib0260) 2010; 41
Do, Kim, Park, Park (bib0660) 2008; 17
Zheng, Yi, Fadare, Liang, Martel, Schwartz (bib0310) 2008; 32
Danialan, Assaad, Burghardt, Newcomb, Cartun, Mandavilli (bib0285) 2013; 130
Samanta, Pursell, Mercurio (bib0185) 2013; 288
Fadare, Liang, Crispens, Jones, Khabele, Gwin (bib0300) 2013; 44
Sitnikova, Mendese, Liu, Woda, Lu, Dresser (bib0495) 2008; 14
Feng, Zhou, Peters, Khoury, Zhai, Wei (bib0365) 2011; 135
Hao, Smith, Chu, Liu, Ok, Woda (bib0630) 2011; 135
Yuan, Wang, Chou, Chang, Lee, Jeng (bib0355) 2009; 16
Patel, Mitra, Harris, Buxbaum, Lionnet, Brenowitz (bib0065) 2012; 26
Won, Gao, Chow, Cheng, Lau, Ellis (bib0265) 2013; 26
Cornejo, Shi, Jiang (bib0665) 2012; 43
Lin, Chen, Jeng, Yeh, Chou, Deng (bib0215) 2011; 40
Bellezza, Cavaliere, Sidoni (bib0530) 2009; 40
Soddu, Di Felice, Cabras, Castellanos, Atzori, Faa (bib0575) 2013; 57
Li, Liu, Chang, Lu, Wang, Wang (bib0680) 2014; 5
Git, Allison, Perdiguero, Nebreda, Houliston, Standart (bib0130) 2009; 15
Wachter, Kristiansen, Soll, Hellerbrand, Breuhahn, Fritzsche (bib0410) 2012; 60
Li, Yan, Tang, Zhou, Fan, Li (bib0340) 2009; 16
Christiansen, Kolte, Hansen, Nielsen (bib0035) 2009; 43
Stoskus, Gineikiene, Valceckiene, Valatkaite, Pileckyte, Griskevicius (bib0655) 2011; 46
Chen, Jeng, Hsu, Lai, Lee, Lai (bib0405) 2013; 11
Elcheva, Goswami, Noubissi, Spiegelman (bib0670) 2009; 35
Mishima, Kato, Kaneko, Nishikawa, Hirose, Matsutani (bib0230) 2006; 111
Chromecki, Cha, Pummer, Scherr, Tewari, Sun (bib0455) 2012; 110
Clauditz, Wang, Gontarewicz, Blessmann, Tennstedt, Borgmann (bib0545) 2013; 42
Kumar, Armenteros-Monterroso, East, Chakravorty, Matthews, Winslow (bib0180) 2014; 505
Aulakh, Chisholm, Smith, Speights (bib0540) 2013; 137
Kabbarah, Nogueira, Feng, Nazarian, Bosenberg, Wu (bib0595) 2010; 5
Yantiss, Woda, Fanger, Kalos, Whalen, Tada (bib0425) 2005; 29
Natkunam, Vainer, Chen, Zhao, Marinelli, Hammer (bib0250) 2007; 92
Wei, Fu, Liu, Xu, Zhao (bib0275) 2013; 6
Jiang, Lohse, Chu, Wu, Woda, Rock (bib0460) 2008; 112
Liao, Hu, Brewer (bib0145) 2011; 286
Rivera Vargas, Boudoukha, Simon, Souidi, Cuvellier, Pinna (bib0090) 2013; 33
Wang, Li, Xia, Lu, Peng (bib0375) 2010; 123
Hart, Parab, Mandich, Cartun, Ligato (bib0385) 2012; 40
Nielsen, Kristensen, Willemoes, Nielsen, Christiansen (bib0070) 2004; 32
Bernstein, Herrick, Prokipcak, Ross (bib0010) 1992; 6
Findeis-Hosey, Yang, Spaulding, Wang, Xu (bib0520) 2010; 41
Findeis-Hosey, Xu (bib0050) 2011; 42
Bell, Wachter, Muhleck, Pazaitis, Kohn, Lederer (bib0005) 2013; 70
Zhao, Mandich, Cartun, Ligato (bib0420) 2007; 35
Yao, Sasaki, Wen, Bassell, Zheng (bib0125) 2006; 9
Wachter, Kohn, Stohr, Huttelmaier (bib0055) 2013; 394
Leung, van Horck, Lin, Allison, Standart, Holt (bib0120) 2006; 9
Okada, Fujiwara, Nakamura, Takiguchi, Nakajima, Miyata (bib0380) 2012; 105
Rudel, Wang, Lenobel, Korner, Hsiao, Urlaub (bib0110) 2011; 39
Jiang, Chu, Woda, Liu, Balaji, Rock (bib0470) 2008; 14
Barton, Donson, Birks, Kleinschmidt-DeMasters, Handler, Foreman (bib0625) 2013; 72
Zhang, Chan, Peng, Tan (bib0030) 1999; 189
Kobel, Xu, Bourne, Spaulding, Shih Ie, Mao (bib0320) 2009; 22
Ross, Oleynikov, Kislauskis, Taneja, Singer (bib0015) 1997; 17
Pryor, Simon, Bourne, Spaulding, Scott, Xu (bib0600) 2009; 40
Jonson, Christiansen, Hansen, Vikesa, Yamamoto, Nielsen (bib0080) 2014; 7
Li, Zota, Woda, Rock, Fraire, Jiang (bib0315) 2007; 20
Hafner, Landthaler, Burger, Khorshid, Hausser, Berninger (bib0140) 2010; 141
Liao, Hu, Herrick, Brewer (bib0150) 2005; 280
Trivedi, Cartun, Ligato (bib0360) 2014; 210
Schaeffer, Owen, Lim, Buczkowski, Chung, Scudamore (bib0435) 2010; 10
Beljan Perak, Durdov, Capkun, Ivcevic, Pavlovic, Soljic (bib0535) 2012; 7
Xu, Bourne, Spaulding, Wang (bib0515) 2007; 38
Yu, Xu, Wasco, Bourne, Ma (bib0580) 2010; 37
Stohr, Kohn, Lederer, Glass, Reinke, Singer (bib0200) 2012; 26
Oleynikov, Singer (bib0105) 2003; 13
Ikenberg, Fritzsche, Zuerrer-Haerdi, Hofmann, Hermanns, Seifert (bib0450) 2010; 10
Hoffmann, Sheinin, Lohse, Parker, Leibovich, Jiang (bib0475) 2008; 112
Lochhead, Imamura, Morikawa, Kuchiba, Yamauchi, Liao (bib0350) 2012; 48
Chen, Jeng, Chang, Chang, Huang, Juan (bib0635) 2011; 102
Weidensdorfer, Stohr, Baude, Lederer, Kohn, Schierhorn (bib0100) 2009; 15
Riener, Kristiansen (bib0390) 2011; 42
Chao, Patskovsky, Patel, Levy, Almo, Singer (bib0060) 2010; 24
Hartmann, Bea, Navarro, Trapp, Campo, Ott (bib0640) 2012; 25
Dai, Christiansen, Nielsen, Avruch (bib0135) 2013; 27
Kim, Li, Cha, Zhang, Cha (bib0560) 2012; 34
Wagner, Kunsch, Duerschmied, Beil, Adler, Mueller (bib0245) 2003; 124
Levy, Lin, Xu, Dhall, Spaulding, Wang (bib0395) 2010; 41
Hu, Wu, Zhou, Xu, Qin, Lu (bib0415) 2014; 140
Li, Xu, Spaulding, Cheng, Simon, Yao (bib0505) 2008; 39
Jeng, Chang, Hu, Chou, Kao, Wang (bib0170) 2008; 48
Dai, Rapley, Angel, Yanik, Blower, Avruch (bib0040) 2011; 25
Chen, Tsukamoto, Liu, Kashiwabara, Feldman, Sher (bib0075) 2013; 123
Ozdemir, Turk, Duzcan (bib0500) 2011; 27
Huttelmaier, Zenklusen, Lederer, Dictenberg, Lorenz, Meng (bib0020) 2005; 438
Mhawech-Fauceglia, Herrmann, Rai, Tchabo, Lele, Izevbaye (bib0305) 2010; 133
Kim, Kim, Lee, Lee, Nam, Choi (bib0370) 2014; 58
Jin, Seys, Zhang, Erickson-Johnson, Roth, Evers (bib0610) 2010; 19
Nielsen, Christiansen, Lykke-Andersen, Johnsen, Wewer, Nielsen (bib0025) 1999; 19
Li, Cha, Kim, Kim, Kim, Nam (bib0220) 2011; 33
Lin, Zhang, Wang, Ju, Ma, Li (bib0345) 2013; 6
Hammer, Hansen, Byskov, Rajpert-De Meyts, Grondahl, Bredkjaer (bib0480) 2005; 130
Stohr (10.1016/j.semcancer.2014.07.006_bib0195) 2012; 6
Samanta (10.1016/j.semcancer.2014.07.006_bib0210) 2012; 31
Pryor (10.1016/j.semcancer.2014.07.006_bib0600) 2009; 40
Pryor (10.1016/j.semcancer.2014.07.006_bib0585) 2008; 21
Li (10.1016/j.semcancer.2014.07.006_bib0220) 2011; 33
Fadare (10.1016/j.semcancer.2014.07.006_bib0300) 2013; 44
Zirkel (10.1016/j.semcancer.2014.07.006_bib0190) 2013; 41
Huttelmaier (10.1016/j.semcancer.2014.07.006_bib0020) 2005; 438
Elcheva (10.1016/j.semcancer.2014.07.006_bib0670) 2009; 35
Sitnikova (10.1016/j.semcancer.2014.07.006_bib0495) 2008; 14
Dai (10.1016/j.semcancer.2014.07.006_bib0040) 2011; 25
Danialan (10.1016/j.semcancer.2014.07.006_bib0285) 2013; 130
Walter (10.1016/j.semcancer.2014.07.006_bib0255) 2009; 40
Vercellini (10.1016/j.semcancer.2014.07.006_bib0295) 2013; 99
Nielsen (10.1016/j.semcancer.2014.07.006_bib0025) 1999; 19
Shi (10.1016/j.semcancer.2014.07.006_bib0400) 2013; 44
King (10.1016/j.semcancer.2014.07.006_bib0645) 2009; 40
Xu (10.1016/j.semcancer.2014.07.006_bib0515) 2007; 38
Wachter (10.1016/j.semcancer.2014.07.006_bib0410) 2012; 60
Tessier (10.1016/j.semcancer.2014.07.006_bib0240) 2004; 64
Vikesaa (10.1016/j.semcancer.2014.07.006_bib0205) 2006; 25
Findeis-Hosey (10.1016/j.semcancer.2014.07.006_bib0050) 2011; 42
Wagner (10.1016/j.semcancer.2014.07.006_bib0245) 2003; 124
Stoskus (10.1016/j.semcancer.2014.07.006_bib0655) 2011; 46
Szarvas (10.1016/j.semcancer.2014.07.006_bib0490) 2012; 110
Hoffmann (10.1016/j.semcancer.2014.07.006_bib0475) 2008; 112
Goodman (10.1016/j.semcancer.2014.07.006_bib0485) 2014
Cornejo (10.1016/j.semcancer.2014.07.006_bib0665) 2012; 43
Li (10.1016/j.semcancer.2014.07.006_bib0340) 2009; 16
Mhawech-Fauceglia (10.1016/j.semcancer.2014.07.006_bib0305) 2010; 133
Gutschner (10.1016/j.semcancer.2014.07.006_bib0175) 2014; 59
Wang (10.1016/j.semcancer.2014.07.006_bib0375) 2010; 123
Hammer (10.1016/j.semcancer.2014.07.006_bib0480) 2005; 130
Natkunam (10.1016/j.semcancer.2014.07.006_bib0250) 2007; 92
Hafner (10.1016/j.semcancer.2014.07.006_bib0140) 2010; 141
Zhang (10.1016/j.semcancer.2014.07.006_bib0325) 2013; 32
Hao (10.1016/j.semcancer.2014.07.006_bib0630) 2011; 135
Rivera Vargas (10.1016/j.semcancer.2014.07.006_bib0090) 2013; 33
Trivedi (10.1016/j.semcancer.2014.07.006_bib0360) 2014; 210
Weidensdorfer (10.1016/j.semcancer.2014.07.006_bib0100) 2009; 15
Lee (10.1016/j.semcancer.2014.07.006_bib0510) 2014; 66
Chromecki (10.1016/j.semcancer.2014.07.006_bib0455) 2012; 110
Kim (10.1016/j.semcancer.2014.07.006_bib0560) 2012; 34
Tang (10.1016/j.semcancer.2014.07.006_bib0650) 2013; 44
Won (10.1016/j.semcancer.2014.07.006_bib0265) 2013; 26
Hartmann (10.1016/j.semcancer.2014.07.006_bib0640) 2012; 25
Clauditz (10.1016/j.semcancer.2014.07.006_bib0545) 2013; 42
Patel (10.1016/j.semcancer.2014.07.006_bib0065) 2012; 26
Mhawech-Fauceglia (10.1016/j.semcancer.2014.07.006_bib0290) 2013; 62
Soddu (10.1016/j.semcancer.2014.07.006_bib0575) 2013; 57
Rudel (10.1016/j.semcancer.2014.07.006_bib0110) 2011; 39
Bell (10.1016/j.semcancer.2014.07.006_bib0005) 2013; 70
Liao (10.1016/j.semcancer.2014.07.006_bib0145) 2011; 286
Jiang (10.1016/j.semcancer.2014.07.006_bib0460) 2008; 112
Yantiss (10.1016/j.semcancer.2014.07.006_bib0425) 2005; 29
Christiansen (10.1016/j.semcancer.2014.07.006_bib0035) 2009; 43
Li (10.1016/j.semcancer.2014.07.006_bib0680) 2014; 5
Bernstein (10.1016/j.semcancer.2014.07.006_bib0010) 1992; 6
Li (10.1016/j.semcancer.2014.07.006_bib0505) 2008; 39
Zheng (10.1016/j.semcancer.2014.07.006_bib0310) 2008; 32
Findeis-Hosey (10.1016/j.semcancer.2014.07.006_bib0520) 2010; 41
Chen (10.1016/j.semcancer.2014.07.006_bib0525) 2013; 44
Wei (10.1016/j.semcancer.2014.07.006_bib0275) 2013; 6
Kabbarah (10.1016/j.semcancer.2014.07.006_bib0595) 2010; 5
Jiang (10.1016/j.semcancer.2014.07.006_bib0465) 2006; 7
Davidson (10.1016/j.semcancer.2014.07.006_bib0335) 2014; 45
Jonson (10.1016/j.semcancer.2014.07.006_bib0080) 2014; 7
Yuan (10.1016/j.semcancer.2014.07.006_bib0355) 2009; 16
Dai (10.1016/j.semcancer.2014.07.006_bib0135) 2013; 27
Okada (10.1016/j.semcancer.2014.07.006_bib0380) 2012; 105
Zhou (10.1016/j.semcancer.2014.07.006_bib0620) 2014; 116
Hart (10.1016/j.semcancer.2014.07.006_bib0385) 2012; 40
Kunita (10.1016/j.semcancer.2014.07.006_bib0235) 2007; 170
Schaeffer (10.1016/j.semcancer.2014.07.006_bib0435) 2010; 10
Wachter (10.1016/j.semcancer.2014.07.006_bib0430) 2011; 35
Suvasini (10.1016/j.semcancer.2014.07.006_bib0155) 2011; 286
Bellezza (10.1016/j.semcancer.2014.07.006_bib0530) 2009; 40
Riener (10.1016/j.semcancer.2014.07.006_bib0390) 2011; 42
Lin (10.1016/j.semcancer.2014.07.006_bib0215) 2011; 40
Do (10.1016/j.semcancer.2014.07.006_bib0660) 2008; 17
Ross (10.1016/j.semcancer.2014.07.006_bib0015) 1997; 17
Asioli (10.1016/j.semcancer.2014.07.006_bib0605) 2010; 23
Chao (10.1016/j.semcancer.2014.07.006_bib0060) 2010; 24
Ikenberg (10.1016/j.semcancer.2014.07.006_bib0450) 2010; 10
Aulakh (10.1016/j.semcancer.2014.07.006_bib0540) 2013; 137
Kim (10.1016/j.semcancer.2014.07.006_bib0370) 2014; 58
Nielsen (10.1016/j.semcancer.2014.07.006_bib0070) 2004; 32
Sidoni (10.1016/j.semcancer.2014.07.006_bib0260) 2010; 41
Liao (10.1016/j.semcancer.2014.07.006_bib0150) 2005; 280
Ostareck-Lederer (10.1016/j.semcancer.2014.07.006_bib0115) 2002; 22
Morimatsu (10.1016/j.semcancer.2014.07.006_bib0440) 2013; 44
Zhao (10.1016/j.semcancer.2014.07.006_bib0420) 2007; 35
Yu (10.1016/j.semcancer.2014.07.006_bib0580) 2010; 37
Li (10.1016/j.semcancer.2014.07.006_bib0315) 2007; 20
Ueki (10.1016/j.semcancer.2014.07.006_bib0085) 2012; 7
Levy (10.1016/j.semcancer.2014.07.006_bib0395) 2010; 41
Ozdemir (10.1016/j.semcancer.2014.07.006_bib0500) 2011; 27
Jin (10.1016/j.semcancer.2014.07.006_bib0610) 2010; 19
Jonson (10.1016/j.semcancer.2014.07.006_bib0095) 2007; 6
Hu (10.1016/j.semcancer.2014.07.006_bib0415) 2014; 140
Hwang (10.1016/j.semcancer.2014.07.006_bib0225) 2012; 33
Mentrikoski (10.1016/j.semcancer.2014.07.006_bib0590) 2009; 22
Lin (10.1016/j.semcancer.2014.07.006_bib0345) 2013; 6
Slosar (10.1016/j.semcancer.2014.07.006_bib0615) 2009; 20
Feng (10.1016/j.semcancer.2014.07.006_bib0365) 2011; 135
Kim (10.1016/j.semcancer.2014.07.006_bib0550) 2011; 47
Yao (10.1016/j.semcancer.2014.07.006_bib0125) 2006; 9
Zhang (10.1016/j.semcancer.2014.07.006_bib0030) 1999; 189
Barton (10.1016/j.semcancer.2014.07.006_bib0625) 2013; 72
Kobel (10.1016/j.semcancer.2014.07.006_bib0320) 2009; 22
Mishima (10.1016/j.semcancer.2014.07.006_bib0230) 2006; 111
Kobel (10.1016/j.semcancer.2014.07.006_bib0330) 2007; 26
Kumar (10.1016/j.semcancer.2014.07.006_bib0180) 2014; 505
Kim (10.1016/j.semcancer.2014.07.006_bib0555) 2012; 138
Szarvas (10.1016/j.semcancer.2014.07.006_bib0445) 2014; 135
Git (10.1016/j.semcancer.2014.07.006_bib0130) 2009; 15
Wachter (10.1016/j.semcancer.2014.07.006_bib0055) 2013; 394
Vranic (10.1016/j.semcancer.2014.07.006_bib0270) 2011; 19
Lastra (10.1016/j.semcancer.2014.07.006_bib0280) 2014; 42
Beljan Perak (10.1016/j.semcancer.2014.07.006_bib0535) 2012; 7
Chen (10.1016/j.semcancer.2014.07.006_bib0075) 2013; 123
Oleynikov (10.1016/j.semcancer.2014.07.006_bib0105) 2003; 13
Samanta (10.1016/j.semcancer.2014.07.006_bib0185) 2013; 288
Stohr (10.1016/j.semcancer.2014.07.006_bib0200) 2012; 26
Chen (10.1016/j.semcancer.2014.07.006_bib0635) 2011; 102
Leung (10.1016/j.semcancer.2014.07.006_bib0120) 2006; 9
Lochhead (10.1016/j.semcancer.2014.07.006_bib0350) 2012; 48
Mueller-Pillasch (10.1016/j.semcancer.2014.07.006_bib0045) 1997; 14
Chen (10.1016/j.semcancer.2014.07.006_bib0405) 2013; 11
Jeng (10.1016/j.semcancer.2014.07.006_bib0170) 2008; 48
Jiang (10.1016/j.semcancer.2014.07.006_bib0470) 2008; 14
References_xml – volume: 38
  start-page: 555
  year: 2007
  end-page: 563
  ident: bib0515
  article-title: High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not
  publication-title: Hum Pathol
– volume: 9
  start-page: 1247
  year: 2006
  end-page: 1256
  ident: bib0120
  article-title: Asymmetrical beta-actin mRNA translation in growth cones mediates attractive turning to netrin-1
  publication-title: Nat Neurosci
– volume: 33
  start-page: 2135
  year: 2012
  end-page: 2146
  ident: bib0225
  article-title: Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression
  publication-title: Carcinogenesis
– volume: 40
  start-page: 699
  year: 2011
  end-page: 705
  ident: bib0215
  article-title: Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma
  publication-title: J Oral Pathol Med
– volume: 72
  start-page: 442
  year: 2013
  end-page: 449
  ident: bib0625
  article-title: Insulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma
  publication-title: J Neuropathol Exp Neurol
– volume: 42
  start-page: 1368
  year: 2011
  ident: bib0390
  article-title: S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy
  publication-title: Hum Pathol
– volume: 99
  start-page: 1974
  year: 2013
  end-page: 1979
  ident: bib0295
  article-title: The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions
  publication-title: Fertil Steril
– volume: 60
  start-page: 278
  year: 2012
  end-page: 286
  ident: bib0410
  article-title: Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value
  publication-title: Histopathology
– volume: 29
  start-page: 188
  year: 2005
  end-page: 195
  ident: bib0425
  article-title: KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas
  publication-title: Am J Surg Pathol
– volume: 19
  start-page: 1262
  year: 1999
  end-page: 1270
  ident: bib0025
  article-title: A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development
  publication-title: Mol Cell Biol
– volume: 280
  start-page: 18517
  year: 2005
  end-page: 18524
  ident: bib0150
  article-title: The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells
  publication-title: J Biol Chem
– volume: 41
  start-page: 1355
  year: 2010
  end-page: 1356
  ident: bib0260
  article-title: IMP3 expression in triple-negative breast carcinoma
  publication-title: Hum Pathol
– volume: 44
  start-page: 1508
  year: 2013
  end-page: 1515
  ident: bib0300
  article-title: Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance
  publication-title: Hum Pathol
– volume: 135
  start-page: 1024
  year: 2011
  end-page: 1031
  ident: bib0365
  article-title: Expression of insulin-like growth factor II mRNA-binding protein 3 in human esophageal adenocarcinoma and its precursor lesions
  publication-title: Arch Pathol Lab Med
– volume: 438
  start-page: 512
  year: 2005
  end-page: 515
  ident: bib0020
  article-title: Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1
  publication-title: Nature
– volume: 26
  start-page: 43
  year: 2012
  end-page: 53
  ident: bib0065
  article-title: Spatial arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control
  publication-title: Genes Dev
– volume: 15
  start-page: 104
  year: 2009
  end-page: 115
  ident: bib0100
  article-title: Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs
  publication-title: RNA
– volume: 25
  start-page: 1159
  year: 2011
  end-page: 1172
  ident: bib0040
  article-title: mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry
  publication-title: Genes Dev
– volume: 64
  start-page: 209
  year: 2004
  end-page: 214
  ident: bib0240
  article-title: Mammary tumor induction in transgenic mice expressing an RNA-binding protein
  publication-title: Cancer Res
– volume: 124
  start-page: 1901
  year: 2003
  end-page: 1914
  ident: bib0245
  article-title: Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas
  publication-title: Gastroenterology
– volume: 130
  start-page: 203
  year: 2005
  end-page: 212
  ident: bib0480
  article-title: Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer
  publication-title: Reproduction
– volume: 31
  start-page: 4689
  year: 2012
  end-page: 4697
  ident: bib0210
  article-title: Regulation of IMP3 by EGFR signaling and repression by ERbeta: implications for triple-negative breast cancer
  publication-title: Oncogene
– volume: 92
  start-page: 176
  year: 2007
  end-page: 183
  ident: bib0250
  article-title: Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms
  publication-title: Haematologica
– volume: 22
  start-page: 4535
  year: 2002
  end-page: 4543
  ident: bib0115
  article-title: c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs
  publication-title: Mol Cell Biol
– volume: 16
  start-page: 3499
  year: 2009
  end-page: 3506
  ident: bib0340
  article-title: IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis
  publication-title: Ann Surg Oncol
– volume: 59
  start-page: 1900
  year: 2014
  end-page: 1911
  ident: bib0175
  article-title: Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma
  publication-title: Hepatology
– volume: 105
  start-page: 780
  year: 2012
  end-page: 785
  ident: bib0380
  article-title: Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma
  publication-title: J Surg Oncol
– volume: 70
  start-page: 2657
  year: 2013
  end-page: 2675
  ident: bib0005
  article-title: Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
  publication-title: Cell Mol Life Sci
– volume: 505
  start-page: 212
  year: 2014
  end-page: 217
  ident: bib0180
  article-title: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
  publication-title: Nature
– year: 2014
  ident: bib0485
  article-title: Differential expression of IMP3 between male and female mature teratomas – immunohistochemical evidence of malignant nature
  publication-title: Histopathology
– volume: 7
  start-page: 539
  year: 2014
  end-page: 551
  ident: bib0080
  article-title: IMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and development
  publication-title: Cell Rep
– volume: 42
  start-page: 303
  year: 2011
  end-page: 314
  ident: bib0050
  article-title: The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology
  publication-title: Hum Pathol
– volume: 17
  start-page: 269
  year: 2008
  end-page: 272
  ident: bib0660
  article-title: Expression of insulin-like growth factor-II mRNA binding protein 3 (IMP3) in osteosarcoma
  publication-title: Oncol Res
– volume: 111
  start-page: 483
  year: 2006
  end-page: 488
  ident: bib0230
  article-title: Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression
  publication-title: Acta Neuropathol
– volume: 6
  start-page: 740
  year: 2013
  end-page: 744
  ident: bib0345
  article-title: Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma
  publication-title: Oncol Lett
– volume: 6
  start-page: 642
  year: 1992
  end-page: 654
  ident: bib0010
  article-title: Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant
  publication-title: Genes Dev
– volume: 40
  start-page: 238
  year: 2009
  end-page: 243
  ident: bib0600
  article-title: Merkel cell carcinoma expresses K homology domain-containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas
  publication-title: Hum Pathol
– volume: 210
  start-page: 402
  year: 2014
  end-page: 406
  ident: bib0360
  article-title: Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma
  publication-title: Pathol Res Pract
– volume: 27
  start-page: 301
  year: 2013
  end-page: 312
  ident: bib0135
  article-title: mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts
  publication-title: Genes Dev
– volume: 34
  start-page: 929
  year: 2012
  end-page: 936
  ident: bib0560
  article-title: Significance of molecular markers in survival prediction of oral squamous cell carcinoma
  publication-title: Head Neck
– volume: 102
  start-page: 2191
  year: 2011
  end-page: 2198
  ident: bib0635
  article-title: Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma
  publication-title: Cancer Sci
– volume: 26
  start-page: 176
  year: 2012
  end-page: 189
  ident: bib0200
  article-title: IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling
  publication-title: Genes Dev
– volume: 35
  start-page: 700
  year: 2007
  end-page: 704
  ident: bib0420
  article-title: Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas
  publication-title: Diagn Cytopathol
– volume: 32
  start-page: 4368
  year: 2004
  end-page: 4376
  ident: bib0070
  article-title: Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability
  publication-title: Nucleic Acids Res
– volume: 140
  start-page: 883
  year: 2014
  end-page: 893
  ident: bib0415
  article-title: IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma
  publication-title: J Cancer Res Clin Oncol
– volume: 35
  start-page: 240
  year: 2009
  end-page: 246
  ident: bib0670
  article-title: CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation
  publication-title: Mol Cell
– volume: 47
  start-page: 1069
  year: 2011
  end-page: 1073
  ident: bib0550
  article-title: A novel algorithm for lymph node status prediction of oral cancer before surgery
  publication-title: Oral Oncol
– volume: 20
  start-page: 149
  year: 2009
  end-page: 157
  ident: bib0615
  article-title: Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors
  publication-title: Endocr Pathol
– volume: 14
  start-page: 1701
  year: 2008
  end-page: 1706
  ident: bib0495
  article-title: IMP3 predicts aggressive superficial urothelial carcinoma of the bladder
  publication-title: Clin Cancer Res
– volume: 40
  start-page: 1699
  year: 2009
  end-page: 1705
  ident: bib0645
  article-title: IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue
  publication-title: Hum Pathol
– volume: 44
  start-page: 2126
  year: 2013
  end-page: 2131
  ident: bib0525
  article-title: Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma
  publication-title: Hum Pathol
– volume: 135
  start-page: 1032
  year: 2011
  end-page: 1036
  ident: bib0630
  article-title: The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma
  publication-title: Arch Pathol Lab Med
– volume: 25
  start-page: 1456
  year: 2006
  end-page: 1468
  ident: bib0205
  article-title: RNA-binding IMPs promote cell adhesion and invadopodia formation
  publication-title: EMBO J
– volume: 286
  start-page: 25882
  year: 2011
  end-page: 25890
  ident: bib0155
  article-title: Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2
  publication-title: J Biol Chem
– volume: 40
  start-page: 321
  year: 2012
  end-page: 326
  ident: bib0385
  article-title: IMP3 immunocytochemical staining increases sensitivity in the routine cytologic evaluation of biliary brush specimens
  publication-title: Diagn Cytopathol
– volume: 46
  start-page: 321
  year: 2011
  end-page: 326
  ident: bib0655
  article-title: Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities
  publication-title: Blood Cells Mol Dis
– volume: 42
  start-page: 375
  year: 2014
  end-page: 379
  ident: bib0280
  article-title: Utility of ProExC and IMP3 immunocytochemical staining in atypical glandular cells of undetermined significance in liquid-based cervical cytology
  publication-title: Diagn Cytopathol
– volume: 123
  start-page: 2832
  year: 2013
  end-page: 2849
  ident: bib0075
  article-title: Reciprocal regulation by TLR4 and TGF-beta in tumor-initiating stem-like cells
  publication-title: J Clin Invest
– volume: 44
  start-page: 1714
  year: 2013
  end-page: 1721
  ident: bib0440
  article-title: Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm
  publication-title: Hum Pathol
– volume: 112
  start-page: 1471
  year: 2008
  end-page: 1479
  ident: bib0475
  article-title: External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma
  publication-title: Cancer
– volume: 62
  start-page: 976
  year: 2013
  end-page: 985
  ident: bib0290
  article-title: ER+/PR+/TFF3+/IMP3− immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases
  publication-title: Histopathology
– volume: 58
  start-page: 167
  year: 2014
  end-page: 173
  ident: bib0370
  article-title: Insulin-like growth factor-II mRNA-binding protein 3 expression in effusion cytology: a marker for metastatic adenocarcinoma cells and a potential prognostic indicator in gastric adenocarcinoma
  publication-title: Acta Cytol
– volume: 37
  start-page: 316
  year: 2010
  end-page: 322
  ident: bib0580
  article-title: IMP-3 expression in melanocytic lesions
  publication-title: J Cutan Pathol
– volume: 24
  start-page: 148
  year: 2010
  end-page: 158
  ident: bib0060
  article-title: ZBP1 recognition of beta-actin zipcode induces RNA looping
  publication-title: Genes Dev
– volume: 21
  start-page: 431
  year: 2008
  end-page: 437
  ident: bib0585
  article-title: IMP-3 is a novel progression marker in malignant melanoma
  publication-title: Mod Pathol
– volume: 33
  start-page: 368
  year: 2011
  end-page: 374
  ident: bib0220
  article-title: Insulin-like growth factor II mRNA-binding protein 3: a novel prognostic biomarker for oral squamous cell carcinoma
  publication-title: Head Neck
– volume: 17
  start-page: 2158
  year: 1997
  end-page: 2165
  ident: bib0015
  article-title: Characterization of a beta-actin mRNA zipcode-binding protein
  publication-title: Mol Cell Biol
– volume: 10
  start-page: 341
  year: 2010
  ident: bib0450
  article-title: Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores
  publication-title: BMC Cancer
– volume: 110
  start-page: E308
  year: 2012
  end-page: E317
  ident: bib0490
  article-title: High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer
  publication-title: BJU Int
– volume: 19
  start-page: 63
  year: 2010
  end-page: 69
  ident: bib0610
  article-title: Diagnostic utility of IMP3 expression in thyroid neoplasms: a quantitative RT-PCR study
  publication-title: Diagn Mol Pathol Am J Surg Pathol B
– volume: 14
  start-page: 5579
  year: 2008
  end-page: 5584
  ident: bib0470
  article-title: Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas
  publication-title: Clin Cancer Res
– volume: 135
  start-page: 1596
  year: 2014
  end-page: 1604
  ident: bib0445
  article-title: Prognostic value of tissue and circulating levels of IMP3 in prostate cancer
  publication-title: Int J Cancer
– volume: 33
  start-page: 2866
  year: 2013
  end-page: 2875
  ident: bib0090
  article-title: Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization
  publication-title: Oncogene
– volume: 41
  start-page: 6618
  year: 2013
  end-page: 6636
  ident: bib0190
  article-title: IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)
  publication-title: Nucleic Acids Res
– volume: 48
  start-page: 1118
  year: 2008
  end-page: 1127
  ident: bib0170
  article-title: RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma
  publication-title: Hepatology
– volume: 5
  start-page: e1025
  year: 2014
  ident: bib0680
  article-title: Role of IGF2BP3 in trophoblast cell invasion and migration
  publication-title: Cell Death Dis
– volume: 43
  start-page: 187
  year: 2009
  end-page: 195
  ident: bib0035
  article-title: IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes
  publication-title: J Mol Endocrinol
– volume: 133
  start-page: 899
  year: 2010
  end-page: 908
  ident: bib0305
  article-title: IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma
  publication-title: Am J Clin Pathol
– volume: 39
  start-page: 2330
  year: 2011
  end-page: 2343
  ident: bib0110
  article-title: Phosphorylation of human Argonaute proteins affects small RNA binding
  publication-title: Nucleic Acids Res
– volume: 26
  start-page: 7584
  year: 2007
  end-page: 7589
  ident: bib0330
  article-title: Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma
  publication-title: Oncogene
– volume: 7
  start-page: e50621
  year: 2012
  ident: bib0085
  article-title: Up-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells
  publication-title: PLoS ONE
– volume: 13
  start-page: 199
  year: 2003
  end-page: 207
  ident: bib0105
  article-title: Real-time visualization of ZBP1 association with beta-actin mRNA during transcription and localization
  publication-title: Curr Biol
– volume: 141
  start-page: 129
  year: 2010
  end-page: 141
  ident: bib0140
  article-title: Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP
  publication-title: Cell
– volume: 123
  start-page: 3554
  year: 2010
  end-page: 3558
  ident: bib0375
  article-title: IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study
  publication-title: Chin Med J (Engl)
– volume: 43
  start-page: 1567
  year: 2012
  end-page: 1572
  ident: bib0665
  article-title: Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma
  publication-title: Hum Pathol
– volume: 44
  start-page: 2167
  year: 2013
  end-page: 2172
  ident: bib0650
  article-title: IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma
  publication-title: Hum Pathol
– volume: 15
  start-page: 1121
  year: 2009
  end-page: 1133
  ident: bib0130
  article-title: Vg1RBP phosphorylation by Erk2 MAP kinase correlates with the cortical release of Vg1 mRNA during meiotic maturation of
  publication-title: RNA
– volume: 22
  start-page: 1582
  year: 2009
  end-page: 1587
  ident: bib0590
  article-title: Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes
  publication-title: Mod Pathol
– volume: 11
  start-page: 85
  year: 2013
  end-page: 91
  ident: bib0405
  article-title: Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma
  publication-title: Int J Surg
– volume: 116
  start-page: 77
  year: 2014
  end-page: 82
  ident: bib0620
  article-title: Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma
  publication-title: J Neurooncol
– volume: 26
  start-page: 1438
  year: 2013
  end-page: 1450
  ident: bib0265
  article-title: A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard
  publication-title: Mod Pathol
– volume: 6
  start-page: 798
  year: 2007
  end-page: 811
  ident: bib0095
  article-title: Molecular composition of IMP1 ribonucleoprotein granules
  publication-title: Mol Cell Proteomics
– volume: 40
  start-page: 1528
  year: 2009
  end-page: 1533
  ident: bib0255
  article-title: IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype
  publication-title: Hum Pathol
– volume: 138
  start-page: 483
  year: 2012
  end-page: 490
  ident: bib0555
  article-title: Risk stratification of oral cancer patients using a combined prognostic factor including lymph node density and biomarker
  publication-title: J Cancer Res Clin Oncol
– volume: 22
  start-page: 469
  year: 2009
  end-page: 475
  ident: bib0320
  article-title: IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
  publication-title: Mod Pathol
– volume: 42
  start-page: 125
  year: 2013
  end-page: 132
  ident: bib0545
  article-title: Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck
  publication-title: J Oral Pathol Med
– volume: 19
  start-page: 413
  year: 2011
  end-page: 416
  ident: bib0270
  article-title: a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast
  publication-title: Appl Immunohistochem Mol Morphol
– volume: 41
  start-page: 1210
  year: 2010
  end-page: 1219
  ident: bib0395
  article-title: S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy
  publication-title: Hum Pathol
– volume: 14
  start-page: 2729
  year: 1997
  end-page: 2733
  ident: bib0045
  article-title: Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein
  publication-title: Oncogene
– volume: 130
  start-page: 383
  year: 2013
  end-page: 388
  ident: bib0285
  article-title: The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions
  publication-title: Gynecol Oncol
– volume: 48
  start-page: 3405
  year: 2012
  end-page: 3413
  ident: bib0350
  article-title: Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer
  publication-title: Eur J Cancer
– volume: 394
  start-page: 1077
  year: 2013
  end-page: 1090
  ident: bib0055
  article-title: Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains
  publication-title: Biol Chem
– volume: 7
  start-page: 165
  year: 2012
  ident: bib0535
  article-title: IMP3 can predict aggressive behaviour of lung adenocarcinoma
  publication-title: Diagn Pathol
– volume: 112
  start-page: 2676
  year: 2008
  end-page: 2682
  ident: bib0460
  article-title: Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas
  publication-title: Cancer
– volume: 32
  start-page: 304
  year: 2008
  end-page: 315
  ident: bib0310
  article-title: The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma
  publication-title: Am J Surg Pathol
– volume: 16
  start-page: 1711
  year: 2009
  end-page: 1719
  ident: bib0355
  article-title: Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma
  publication-title: Ann Surg Oncol
– volume: 7
  start-page: 556
  year: 2006
  end-page: 564
  ident: bib0465
  article-title: Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study
  publication-title: Lancet Oncol
– volume: 40
  start-page: 1205
  year: 2009
  end-page: 1206
  ident: bib0530
  article-title: IMP3 expression in non-small cell lung cancer
  publication-title: Hum Pathol
– volume: 23
  start-page: 1269
  year: 2010
  end-page: 1278
  ident: bib0605
  article-title: Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression
  publication-title: Mod Pathol
– volume: 110
  start-page: 63
  year: 2012
  end-page: 68
  ident: bib0455
  article-title: Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy
  publication-title: BJU Int
– volume: 6
  start-page: 1549
  year: 2013
  end-page: 1557
  ident: bib0275
  article-title: Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosis
  publication-title: Int J Clin Exp Pathol
– volume: 41
  start-page: 477
  year: 2010
  end-page: 484
  ident: bib0520
  article-title: IMP3 expression is correlated with histologic grade of lung adenocarcinoma
  publication-title: Hum Pathol
– volume: 32
  start-page: 476
  year: 2013
  end-page: 481
  ident: bib0325
  article-title: An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas
  publication-title: Int J Gynecol Pathol
– volume: 44
  start-page: 503
  year: 2013
  end-page: 511
  ident: bib0400
  article-title: Diagnostic utility of von Hippel-Lindau gene product, maspin, IMP3, and S100P in adenocarcinoma of the gallbladder
  publication-title: Hum Pathol
– volume: 189
  start-page: 1101
  year: 1999
  end-page: 1110
  ident: bib0030
  article-title: A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma
  publication-title: J Exp Med
– volume: 286
  start-page: 31145
  year: 2011
  end-page: 31152
  ident: bib0145
  article-title: RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation
  publication-title: J Biol Chem
– volume: 66
  start-page: 379
  year: 2014
  end-page: 385
  ident: bib0510
  article-title: Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma
  publication-title: Eur Urol
– volume: 9
  start-page: 1265
  year: 2006
  end-page: 1273
  ident: bib0125
  article-title: An essential role for beta-actin mRNA localization and translation in Ca
  publication-title: Nat Neurosci
– volume: 25
  start-page: 1227
  year: 2012
  end-page: 1235
  ident: bib0640
  article-title: Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression
  publication-title: Mod Pathol
– volume: 20
  start-page: 1263
  year: 2007
  end-page: 1268
  ident: bib0315
  article-title: Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations
  publication-title: Mod Pathol
– volume: 6
  start-page: 312
  year: 2012
  end-page: 318
  ident: bib0195
  article-title: IGF2BP1: a post-transcriptional driver of tumor cell migration
  publication-title: Cell Adh Migr
– volume: 10
  start-page: 59
  year: 2010
  ident: bib0435
  article-title: Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
  publication-title: BMC Cancer
– volume: 137
  start-page: 1094
  year: 2013
  end-page: 1098
  ident: bib0540
  article-title: TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel
  publication-title: Arch Pathol Lab Med
– volume: 27
  start-page: 31
  year: 2011
  end-page: 37
  ident: bib0500
  article-title: IMP3 expression in urothelial carcinomas of the urinary bladder
  publication-title: Turk patoloji dergisi
– volume: 39
  start-page: 1205
  year: 2008
  end-page: 1211
  ident: bib0505
  article-title: Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors
  publication-title: Hum Pathol
– volume: 35
  start-page: 873
  year: 2011
  end-page: 877
  ident: bib0430
  article-title: Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma
  publication-title: Am J Surg Pathol
– volume: 5
  start-page: e10770
  year: 2010
  ident: bib0595
  article-title: Integrative genome comparison of primary and metastatic melanomas
  publication-title: PLoS ONE
– volume: 170
  start-page: 1337
  year: 2007
  end-page: 1347
  ident: bib0235
  article-title: The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis
  publication-title: Am J Pathol
– volume: 45
  start-page: 1520
  year: 2014
  end-page: 1528
  ident: bib0335
  article-title: VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival
  publication-title: Hum Pathol
– volume: 57
  start-page: e6
  year: 2013
  ident: bib0575
  article-title: IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study
  publication-title: Eur J Histochem
– volume: 288
  start-page: 12569
  year: 2013
  end-page: 12573
  ident: bib0185
  article-title: IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression
  publication-title: J Biol Chem
– volume: 34
  start-page: 929
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0560
  article-title: Significance of molecular markers in survival prediction of oral squamous cell carcinoma
  publication-title: Head Neck
  doi: 10.1002/hed.21856
– volume: 110
  start-page: 63
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0455
  article-title: Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2011.10703.x
– volume: 25
  start-page: 1159
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0040
  article-title: mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry
  publication-title: Genes Dev
  doi: 10.1101/gad.2042311
– volume: 288
  start-page: 12569
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0185
  article-title: IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression
  publication-title: J Biol Chem
  doi: 10.1074/jbc.C112.442319
– volume: 40
  start-page: 699
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0215
  article-title: Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma
  publication-title: J Oral Pathol Med
  doi: 10.1111/j.1600-0714.2011.01019.x
– volume: 189
  start-page: 1101
  year: 1999
  ident: 10.1016/j.semcancer.2014.07.006_bib0030
  article-title: A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma
  publication-title: J Exp Med
  doi: 10.1084/jem.189.7.1101
– volume: 138
  start-page: 483
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0555
  article-title: Risk stratification of oral cancer patients using a combined prognostic factor including lymph node density and biomarker
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-011-1129-3
– volume: 10
  start-page: 59
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0435
  article-title: Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-10-59
– volume: 42
  start-page: 125
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0545
  article-title: Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck
  publication-title: J Oral Pathol Med
  doi: 10.1111/j.1600-0714.2012.01178.x
– volume: 210
  start-page: 402
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0360
  article-title: Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma
  publication-title: Pathol Res Pract
  doi: 10.1016/j.prp.2014.01.018
– volume: 9
  start-page: 1265
  year: 2006
  ident: 10.1016/j.semcancer.2014.07.006_bib0125
  article-title: An essential role for beta-actin mRNA localization and translation in Ca2+-dependent growth cone guidance
  publication-title: Nat Neurosci
  doi: 10.1038/nn1773
– volume: 21
  start-page: 431
  year: 2008
  ident: 10.1016/j.semcancer.2014.07.006_bib0585
  article-title: IMP-3 is a novel progression marker in malignant melanoma
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.3801016
– volume: 40
  start-page: 1699
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0645
  article-title: IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2009.05.003
– volume: 33
  start-page: 368
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0220
  article-title: Insulin-like growth factor II mRNA-binding protein 3: a novel prognostic biomarker for oral squamous cell carcinoma
  publication-title: Head Neck
  doi: 10.1002/hed.21457
– volume: 25
  start-page: 1227
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0640
  article-title: Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2012.84
– volume: 38
  start-page: 555
  year: 2007
  ident: 10.1016/j.semcancer.2014.07.006_bib0515
  article-title: High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2006.11.011
– volume: 41
  start-page: 477
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0520
  article-title: IMP3 expression is correlated with histologic grade of lung adenocarcinoma
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2009.10.004
– volume: 41
  start-page: 1210
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0395
  article-title: S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2010.01.014
– volume: 137
  start-page: 1094
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0540
  article-title: TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2012-0305-OA
– volume: 19
  start-page: 413
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0270
  article-title: a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast
  publication-title: Appl Immunohistochem Mol Morphol
  doi: 10.1097/PAI.0b013e3182143399
– volume: 14
  start-page: 1701
  year: 2008
  ident: 10.1016/j.semcancer.2014.07.006_bib0495
  article-title: IMP3 predicts aggressive superficial urothelial carcinoma of the bladder
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-2039
– volume: 45
  start-page: 1520
  issue: 7
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0335
  article-title: VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2014.03.005
– volume: 32
  start-page: 304
  year: 2008
  ident: 10.1016/j.semcancer.2014.07.006_bib0310
  article-title: The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e3181483ff8
– volume: 72
  start-page: 442
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0625
  article-title: Insulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/NEN.0b013e31829023dd
– volume: 39
  start-page: 2330
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0110
  article-title: Phosphorylation of human Argonaute proteins affects small RNA binding
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkq1032
– volume: 59
  start-page: 1900
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0175
  article-title: Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.26997
– volume: 42
  start-page: 1368
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0390
  article-title: S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2011.05.012
– volume: 35
  start-page: 700
  year: 2007
  ident: 10.1016/j.semcancer.2014.07.006_bib0420
  article-title: Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas
  publication-title: Diagn Cytopathol
  doi: 10.1002/dc.20739
– volume: 123
  start-page: 2832
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0075
  article-title: Reciprocal regulation by TLR4 and TGF-beta in tumor-initiating stem-like cells
  publication-title: J Clin Invest
  doi: 10.1172/JCI65859
– volume: 26
  start-page: 7584
  year: 2007
  ident: 10.1016/j.semcancer.2014.07.006_bib0330
  article-title: Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210563
– volume: 40
  start-page: 321
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0385
  article-title: IMP3 immunocytochemical staining increases sensitivity in the routine cytologic evaluation of biliary brush specimens
  publication-title: Diagn Cytopathol
  doi: 10.1002/dc.21571
– volume: 32
  start-page: 476
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0325
  article-title: An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas
  publication-title: Int J Gynecol Pathol
  doi: 10.1097/PGP.0b013e31826ddc4e
– volume: 24
  start-page: 148
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0060
  article-title: ZBP1 recognition of beta-actin zipcode induces RNA looping
  publication-title: Genes Dev
  doi: 10.1101/gad.1862910
– volume: 286
  start-page: 31145
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0145
  article-title: RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.263913
– volume: 39
  start-page: 1205
  year: 2008
  ident: 10.1016/j.semcancer.2014.07.006_bib0505
  article-title: Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2007.12.012
– volume: 58
  start-page: 167
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0370
  article-title: Insulin-like growth factor-II mRNA-binding protein 3 expression in effusion cytology: a marker for metastatic adenocarcinoma cells and a potential prognostic indicator in gastric adenocarcinoma
  publication-title: Acta Cytol
  doi: 10.1159/000357199
– volume: 123
  start-page: 3554
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0375
  article-title: IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study
  publication-title: Chin Med J (Engl)
– volume: 66
  start-page: 379
  issue: 2
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0510
  article-title: Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2013.12.008
– volume: 112
  start-page: 1471
  year: 2008
  ident: 10.1016/j.semcancer.2014.07.006_bib0475
  article-title: External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma
  publication-title: Cancer
  doi: 10.1002/cncr.23296
– volume: 6
  start-page: 642
  year: 1992
  ident: 10.1016/j.semcancer.2014.07.006_bib0010
  article-title: Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant
  publication-title: Genes Dev
  doi: 10.1101/gad.6.4.642
– volume: 44
  start-page: 2126
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0525
  article-title: Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2013.04.002
– volume: 102
  start-page: 2191
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0635
  article-title: Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2011.02100.x
– volume: 41
  start-page: 6618
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0190
  article-title: IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkt410
– volume: 135
  start-page: 1596
  issue: 7
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0445
  article-title: Prognostic value of tissue and circulating levels of IMP3 in prostate cancer
  publication-title: Int J Cancer
  doi: 10.1002/ijc.28808
– volume: 280
  start-page: 18517
  year: 2005
  ident: 10.1016/j.semcancer.2014.07.006_bib0150
  article-title: The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M500270200
– volume: 11
  start-page: 85
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0405
  article-title: Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma
  publication-title: Int J Surg
  doi: 10.1016/j.ijsu.2012.11.021
– volume: 60
  start-page: 278
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0410
  article-title: Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2011.04091.x
– volume: 92
  start-page: 176
  year: 2007
  ident: 10.1016/j.semcancer.2014.07.006_bib0250
  article-title: Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms
  publication-title: Haematologica
  doi: 10.3324/haematol.10724
– volume: 9
  start-page: 1247
  year: 2006
  ident: 10.1016/j.semcancer.2014.07.006_bib0120
  article-title: Asymmetrical beta-actin mRNA translation in growth cones mediates attractive turning to netrin-1
  publication-title: Nat Neurosci
  doi: 10.1038/nn1775
– volume: 15
  start-page: 104
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0100
  article-title: Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs
  publication-title: RNA
  doi: 10.1261/rna.1175909
– volume: 130
  start-page: 383
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0285
  article-title: The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2013.04.020
– volume: 47
  start-page: 1069
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0550
  article-title: A novel algorithm for lymph node status prediction of oral cancer before surgery
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2011.07.017
– volume: 22
  start-page: 4535
  year: 2002
  ident: 10.1016/j.semcancer.2014.07.006_bib0115
  article-title: c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.22.13.4535-4543.2002
– volume: 26
  start-page: 43
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0065
  article-title: Spatial arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control
  publication-title: Genes Dev
  doi: 10.1101/gad.177428.111
– volume: 48
  start-page: 3405
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0350
  article-title: Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2012.06.021
– volume: 46
  start-page: 321
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0655
  article-title: Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities
  publication-title: Blood Cells Mol Dis
  doi: 10.1016/j.bcmd.2011.02.005
– volume: 6
  start-page: 1549
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0275
  article-title: Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosis
  publication-title: Int J Clin Exp Pathol
– volume: 35
  start-page: 873
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0430
  article-title: Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e3182189223
– volume: 43
  start-page: 1567
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0665
  article-title: Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2011.12.020
– volume: 44
  start-page: 2167
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0650
  article-title: IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2013.04.011
– volume: 111
  start-page: 483
  year: 2006
  ident: 10.1016/j.semcancer.2014.07.006_bib0230
  article-title: Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-006-0063-y
– volume: 124
  start-page: 1901
  year: 2003
  ident: 10.1016/j.semcancer.2014.07.006_bib0245
  article-title: Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(03)00402-5
– volume: 7
  start-page: 556
  year: 2006
  ident: 10.1016/j.semcancer.2014.07.006_bib0465
  article-title: Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(06)70732-X
– volume: 40
  start-page: 1528
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0255
  article-title: IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2009.05.005
– volume: 15
  start-page: 1121
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0130
  article-title: Vg1RBP phosphorylation by Erk2 MAP kinase correlates with the cortical release of Vg1 mRNA during meiotic maturation of Xenopus oocytes
  publication-title: RNA
  doi: 10.1261/rna.1195709
– volume: 7
  start-page: 165
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0535
  article-title: IMP3 can predict aggressive behaviour of lung adenocarcinoma
  publication-title: Diagn Pathol
  doi: 10.1186/1746-1596-7-165
– volume: 6
  start-page: 740
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0345
  article-title: Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma
  publication-title: Oncol Lett
  doi: 10.3892/ol.2013.1458
– volume: 64
  start-page: 209
  year: 2004
  ident: 10.1016/j.semcancer.2014.07.006_bib0240
  article-title: Mammary tumor induction in transgenic mice expressing an RNA-binding protein
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-03-2927
– volume: 31
  start-page: 4689
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0210
  article-title: Regulation of IMP3 by EGFR signaling and repression by ERbeta: implications for triple-negative breast cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2011.620
– volume: 44
  start-page: 1508
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0300
  article-title: Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2012.12.003
– volume: 5
  start-page: e10770
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0595
  article-title: Integrative genome comparison of primary and metastatic melanomas
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0010770
– volume: 26
  start-page: 1438
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0265
  article-title: A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2013.97
– volume: 7
  start-page: 539
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0080
  article-title: IMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and development
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.03.015
– volume: 35
  start-page: 240
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0670
  article-title: CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2009.06.007
– volume: 99
  start-page: 1974
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0295
  article-title: The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2013.02.002
– year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0485
  article-title: Differential expression of IMP3 between male and female mature teratomas – immunohistochemical evidence of malignant nature
  publication-title: Histopathology
  doi: 10.1111/his.12409
– volume: 17
  start-page: 2158
  year: 1997
  ident: 10.1016/j.semcancer.2014.07.006_bib0015
  article-title: Characterization of a beta-actin mRNA zipcode-binding protein
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.17.4.2158
– volume: 41
  start-page: 1355
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0260
  article-title: IMP3 expression in triple-negative breast carcinoma
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2010.05.004
– volume: 44
  start-page: 1714
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0440
  article-title: Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2012.12.020
– volume: 16
  start-page: 3499
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0340
  article-title: IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-009-0648-5
– volume: 170
  start-page: 1337
  year: 2007
  ident: 10.1016/j.semcancer.2014.07.006_bib0235
  article-title: The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2007.060790
– volume: 286
  start-page: 25882
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0155
  article-title: Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.178012
– volume: 33
  start-page: 2135
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0225
  article-title: Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgs258
– volume: 141
  start-page: 129
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0140
  article-title: Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP
  publication-title: Cell
  doi: 10.1016/j.cell.2010.03.009
– volume: 70
  start-page: 2657
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0005
  article-title: Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-012-1186-z
– volume: 27
  start-page: 301
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0135
  article-title: mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts
  publication-title: Genes Dev
  doi: 10.1101/gad.209130.112
– volume: 27
  start-page: 31
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0500
  article-title: IMP3 expression in urothelial carcinomas of the urinary bladder
  publication-title: Turk patoloji dergisi
– volume: 37
  start-page: 316
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0580
  article-title: IMP-3 expression in melanocytic lesions
  publication-title: J Cutan Pathol
  doi: 10.1111/j.1600-0560.2009.01428.x
– volume: 505
  start-page: 212
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0180
  article-title: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
  publication-title: Nature
  doi: 10.1038/nature12785
– volume: 7
  start-page: e50621
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0085
  article-title: Up-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0050621
– volume: 57
  start-page: e6
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0575
  article-title: IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study
  publication-title: Eur J Histochem
  doi: 10.4081/ejh.2013.e6
– volume: 26
  start-page: 176
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0200
  article-title: IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling
  publication-title: Genes Dev
  doi: 10.1101/gad.177642.111
– volume: 135
  start-page: 1032
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0630
  article-title: The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/2009-0652-OAR2
– volume: 23
  start-page: 1269
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0605
  article-title: Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2010.117
– volume: 6
  start-page: 798
  year: 2007
  ident: 10.1016/j.semcancer.2014.07.006_bib0095
  article-title: Molecular composition of IMP1 ribonucleoprotein granules
  publication-title: Mol Cell Proteomics
  doi: 10.1074/mcp.M600346-MCP200
– volume: 14
  start-page: 2729
  year: 1997
  ident: 10.1016/j.semcancer.2014.07.006_bib0045
  article-title: Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1201110
– volume: 62
  start-page: 976
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0290
  article-title: ER+/PR+/TFF3+/IMP3− immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases
  publication-title: Histopathology
  doi: 10.1111/his.12096
– volume: 20
  start-page: 1263
  year: 2007
  ident: 10.1016/j.semcancer.2014.07.006_bib0315
  article-title: Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.3800960
– volume: 105
  start-page: 780
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0380
  article-title: Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma
  publication-title: J Surg Oncol
  doi: 10.1002/jso.22108
– volume: 42
  start-page: 303
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0050
  article-title: The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2010.06.003
– volume: 19
  start-page: 63
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0610
  article-title: Diagnostic utility of IMP3 expression in thyroid neoplasms: a quantitative RT-PCR study
  publication-title: Diagn Mol Pathol Am J Surg Pathol B
  doi: 10.1097/PDM.0b013e3181b6a528
– volume: 394
  start-page: 1077
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0055
  article-title: Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains
  publication-title: Biol Chem
  doi: 10.1515/hsz-2013-0111
– volume: 48
  start-page: 1118
  year: 2008
  ident: 10.1016/j.semcancer.2014.07.006_bib0170
  article-title: RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.22459
– volume: 16
  start-page: 1711
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0355
  article-title: Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-009-0446-0
– volume: 112
  start-page: 2676
  year: 2008
  ident: 10.1016/j.semcancer.2014.07.006_bib0460
  article-title: Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas
  publication-title: Cancer
  doi: 10.1002/cncr.23484
– volume: 17
  start-page: 269
  year: 2008
  ident: 10.1016/j.semcancer.2014.07.006_bib0660
  article-title: Expression of insulin-like growth factor-II mRNA binding protein 3 (IMP3) in osteosarcoma
  publication-title: Oncol Res
  doi: 10.3727/096504008786991639
– volume: 133
  start-page: 899
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0305
  article-title: IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma
  publication-title: Am J Clin Pathol
  doi: 10.1309/AJCPQDQXJ4FNRFQB
– volume: 14
  start-page: 5579
  year: 2008
  ident: 10.1016/j.semcancer.2014.07.006_bib0470
  article-title: Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-08-0504
– volume: 29
  start-page: 188
  year: 2005
  ident: 10.1016/j.semcancer.2014.07.006_bib0425
  article-title: KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas
  publication-title: Am J Surg Pathol
  doi: 10.1097/01.pas.0000149688.98333.54
– volume: 19
  start-page: 1262
  year: 1999
  ident: 10.1016/j.semcancer.2014.07.006_bib0025
  article-title: A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.19.2.1262
– volume: 135
  start-page: 1024
  year: 2011
  ident: 10.1016/j.semcancer.2014.07.006_bib0365
  article-title: Expression of insulin-like growth factor II mRNA-binding protein 3 in human esophageal adenocarcinoma and its precursor lesions
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/2009-0617-OAR2
– volume: 438
  start-page: 512
  year: 2005
  ident: 10.1016/j.semcancer.2014.07.006_bib0020
  article-title: Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1
  publication-title: Nature
  doi: 10.1038/nature04115
– volume: 43
  start-page: 187
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0035
  article-title: IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes
  publication-title: J Mol Endocrinol
  doi: 10.1677/JME-09-0016
– volume: 44
  start-page: 503
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0400
  article-title: Diagnostic utility of von Hippel-Lindau gene product, maspin, IMP3, and S100P in adenocarcinoma of the gallbladder
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2012.06.010
– volume: 22
  start-page: 469
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0320
  article-title: IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2008.206
– volume: 116
  start-page: 77
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0620
  article-title: Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma
  publication-title: J Neurooncol
  doi: 10.1007/s11060-013-1274-4
– volume: 40
  start-page: 1205
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0530
  article-title: IMP3 expression in non-small cell lung cancer
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2009.03.019
– volume: 25
  start-page: 1456
  year: 2006
  ident: 10.1016/j.semcancer.2014.07.006_bib0205
  article-title: RNA-binding IMPs promote cell adhesion and invadopodia formation
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7601039
– volume: 140
  start-page: 883
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0415
  article-title: IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-014-1639-x
– volume: 20
  start-page: 149
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0615
  article-title: Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors
  publication-title: Endocr Pathol
  doi: 10.1007/s12022-009-9079-x
– volume: 22
  start-page: 1582
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0590
  article-title: Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2009.128
– volume: 110
  start-page: E308
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0490
  article-title: High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2012.11149.x
– volume: 10
  start-page: 341
  year: 2010
  ident: 10.1016/j.semcancer.2014.07.006_bib0450
  article-title: Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-10-341
– volume: 40
  start-page: 238
  year: 2009
  ident: 10.1016/j.semcancer.2014.07.006_bib0600
  article-title: Merkel cell carcinoma expresses K homology domain-containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2008.07.009
– volume: 13
  start-page: 199
  year: 2003
  ident: 10.1016/j.semcancer.2014.07.006_bib0105
  article-title: Real-time visualization of ZBP1 association with beta-actin mRNA during transcription and localization
  publication-title: Curr Biol
  doi: 10.1016/S0960-9822(03)00044-7
– volume: 6
  start-page: 312
  year: 2012
  ident: 10.1016/j.semcancer.2014.07.006_bib0195
  article-title: IGF2BP1: a post-transcriptional driver of tumor cell migration
  publication-title: Cell Adh Migr
  doi: 10.4161/cam.20628
– volume: 42
  start-page: 375
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0280
  article-title: Utility of ProExC and IMP3 immunocytochemical staining in atypical glandular cells of undetermined significance in liquid-based cervical cytology
  publication-title: Diagn Cytopathol
  doi: 10.1002/dc.23029
– volume: 130
  start-page: 203
  year: 2005
  ident: 10.1016/j.semcancer.2014.07.006_bib0480
  article-title: Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer
  publication-title: Reproduction
  doi: 10.1530/rep.1.00664
– volume: 32
  start-page: 4368
  year: 2004
  ident: 10.1016/j.semcancer.2014.07.006_bib0070
  article-title: Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkh754
– volume: 33
  start-page: 2866
  issue: 22
  year: 2013
  ident: 10.1016/j.semcancer.2014.07.006_bib0090
  article-title: Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization
  publication-title: Oncogene
  doi: 10.1038/onc.2013.252
– volume: 5
  start-page: e1025
  year: 2014
  ident: 10.1016/j.semcancer.2014.07.006_bib0680
  article-title: Role of IGF2BP3 in trophoblast cell invasion and migration
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2013.545
SSID ssj0009414
Score 2.5479805
SecondaryResourceType review_article
Snippet The post-transcriptional control of gene expression mediated by RNA-binding proteins (RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is essential to...
Abstract The post-transcriptional control of gene expression mediated by RNA-binding proteins (RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3
SubjectTerms Antigens, Neoplasm - genetics
Cell Proliferation
Cell Transformation, Neoplastic - genetics
CRD-BP
Drug Resistance, Neoplasm - genetics
Gene Expression Regulation, Neoplastic
Hematology, Oncology and Palliative Medicine
Humans
IGF2 mRNA-binding protein
IGF2BP
IMP
Neoplasm Metastasis - genetics
Neoplasm Metastasis - pathology
Neoplasms - genetics
Neoplasms - pathology
RNA-Binding Proteins - biosynthesis
RNA-Binding Proteins - genetics
VICKZ
Title The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1044579X14000947
https://www.clinicalkey.es/playcontent/1-s2.0-S1044579X14000947
https://dx.doi.org/10.1016/j.semcancer.2014.07.006
https://www.ncbi.nlm.nih.gov/pubmed/25068994
https://www.proquest.com/docview/1652382185
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9tAEB5CAqWXkjh9uEnMFkppD6ol7VO5OSGu3RJT2gZ8W6zVChxqKcTOIZf89szo4RCSkEKPWu2w0mge32hnZgE-Cid5mGBYEqVZSE2188BIFwUynEXaCZ8KRfXOpxM1OhPfp3K6AcdtLQylVTa2v7bplbVuRvoNN_sX83n_NwYSQupkiiEC5cdRRbkQmqT8681dmkciqv7eNDmg2fdyvJZ-4Yi51Bg0ElUXTzr66HEP9RQCrTzRcBteNRCSDeqn3IENX3Rgd1Bg-Ly4Zp9YldRZ_S3vwIvTZu98F8YoEYySCVmZM4R9rCxcmXsE32z8bRizxa_JgOJkcmasat8wLxhnn-nm0U_-heFl_Rqv4Wx48ud4FDQHKQRORWYVGKcV4RwfxxiSai1ThUAtypLYZDzPEIV4n0dpwlONiEXJOOdK40AunMHwJuRvYLMoC_8OmCGIpaWcofKLXISpo5Z2JovREc546rugWuZZ13QZp8Mu_to2nezcrrluies2pB1w1YVwTXhRN9p4nsS0X8e2daRo-Sw6g-dJ9WOkftlo8NJGdhnb0D6Qsi4crinvCeq_LfuhFSKLakx7M7PCl1e4HHKdG8Rbsgtva-laswFRqsKwWLz_n6X34CVd1Zk4-7C5urzyB4inVmmvUpgebA3GP0aTW2qnGbo
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-NTgJeEGx8lI_hSROCh6hJ_FneyrTSbmuFYJP6ZjWOIxXRZKLdA_89d4nTadqmIfEYOycnlzvf7-LzzwAHwkke9zEtSbI8JlLtIjLSJZGM54l2wmdC0X7nyVSNzsXxTM624LDdC0NllWHub-b0erYOLb2gzd7FYtH7gYmEkLo_wxSB6uP0A9gmdirZge3B-GQ0veLeFTXFN90fkcC1Mq-VXzrSL3GDJqIm8qTTj24PUneB0DoYDZ_Ck4Ai2aB50Gew5csd2B2UmEEv_7APrK7rrH-Y78DDSVg-34UxGgWjekJWFQyRH6tKVxUe8Tcbfx2mbPl9OqBUmeIZqxkcFiXj7CN1fvnGPzG8bF7jOZwPj84OR1E4SyFyKjHryDitCOr4NMWsVGuZKcRqSd5PTc6LHIGI90WS9XmmEbQomRZcaWwohDOY4cT8BXTKqvSvgBlCWVrKOfq_KEScOWK1M3mKsXDOM98F1SrPukA0Tudd_LJtRdlPu9G6Ja3bmBbBVRfijeBFw7Vxv4hpv45tt5Li5GcxHtwvqm8T9avgxCub2FVqY3vD0LrweSN5zVb_bdj91ogsejItz8xLX13icKh1bhByyS68bKxrowYEqgozY_H6f4Z-D49GZ5NTezqenryBx9TTFOa8hc7696V_h_Bqne0F9_kLDU0caw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+the+oncofetal+IGF2+mRNA-binding+protein+3+%28IGF2BP3%29+in+cancer&rft.jtitle=Seminars+in+cancer+biology&rft.au=Lederer%2C+Marcell&rft.au=Bley%2C+Nadine&rft.au=Schleifer%2C+Christian&rft.au=H%C3%BCttelmaier%2C+Stefan&rft.date=2014-12-01&rft.eissn=1096-3650&rft.volume=29&rft.spage=3&rft_id=info:doi/10.1016%2Fj.semcancer.2014.07.006&rft_id=info%3Apmid%2F25068994&rft.externalDocID=25068994
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F1044579X%2FS1044579X14X00076%2Fcov150h.gif